Recognized multiple times as a top oncologist in the Bay Area, Dr. Peter Brett now serves as an oncologist at the Commonwealth Health Care Corp (CHCC) Center in Saipan. His presence has greatly boosted the cancer-treating capability of the Western Pacific island. Dr. Peter Brett keeps abreast of the latest developments in oncology through membership with the American Society of Clinical Oncology (ASCO).
ASCO is the world’s premier professional organization for health care practitioners looking after patients with cancer. In January 2020, the organization launched the Association for Clinical Oncology. While ASCO is a 501(c)(3) nonprofit organization, the Association for Clinical Oncology was purposely established as a 501(c)(6) nonprofit. This type of group has greater leeway in how it can advocate for issues on behalf of its members.
Other medical organizations have also used this designation. In the health care space, we are now experiencing a fast-paced world of scientific advances, cost increases, health care system shifts, and other pressing issues. Having a 501(c)(6) entity will give ASCO the adaptability to provide policymakers with a better understanding of the present challenges the cancer care delivery system is facing and the potential to provide better care.
ASCO is the world’s premier professional organization for health care practitioners looking after patients with cancer. In January 2020, the organization launched the Association for Clinical Oncology. While ASCO is a 501(c)(3) nonprofit organization, the Association for Clinical Oncology was purposely established as a 501(c)(6) nonprofit. This type of group has greater leeway in how it can advocate for issues on behalf of its members.
Other medical organizations have also used this designation. In the health care space, we are now experiencing a fast-paced world of scientific advances, cost increases, health care system shifts, and other pressing issues. Having a 501(c)(6) entity will give ASCO the adaptability to provide policymakers with a better understanding of the present challenges the cancer care delivery system is facing and the potential to provide better care.
